Skip to content

Fighting fatigue! An intervention to reduce fatigue.

Fighting fatigue! An intervention to reduce fatigue. - Fighting fatigue!

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43728
Enrollment
74
Registered
2016-08-25
Start date
2015-10-30
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vermoeidheid Fatigue tiredness

Interventions

Psychosocial treatment (intervention group) VS regular treatment without psychosocial treatment (control group). The psychosocial intervention consists of 4-6 individual sessions with a medical soci
Dialysis patients
Fatigue
Psychosocial intervention

Sponsors

Nierstichting
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Kidney patients (M / F) who: ;- Undergo daytime dialysis (PD, HD, both at home and in the hospital or dialysis center); - Experience (severe) fatigue; - Are 18 years or older; - Are in the ability of physical activity (walk/move at least 10 minutes with or without supporting device such as a walking stick); - Are sufficient in Dutch (understanding, conversation, reading) in order to participate in (group)interviews and to fill out Dutch questionnaires.

Exclusion criteria

Exclusion criteria: Patients can not participate in the study under circumstances of: - Participation in other research or treatment aimed at reducing fatigue; - Treatment by a psychologist or psychiatrist (for severe psychiatric problems such as depression, psychosis, personality disorders or schizophrenia); - Alcohol or drug addiction.

Design outcomes

Primary

MeasureTime frame
Primary outcome: The difference in perceived fatigue between intervention group and control group (measured with the CIS-fatigue). (Note: Repeated measures over time (T0t/mT4), within and between groups).

Secondary

MeasureTime frame
Secondary outcome: The difference in perceived quality of life between the intervention group and control group (measured by the SF-KDQOL). (Note: Repeated measures over time (T0 t/m T4), within and between groups).

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)